Modeling the potential impact of providing ART and OAT in prison and upon release on HIV incidence among PWID in Tijuana, Mexico Add other affiliations.

Slides:



Advertisements
Similar presentations
The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
Advertisements

Police Brutality is Independently Associated with Sharing Injection Equipment among Injection Drug Users in Odessa, Ukraine Supported by the National Institute.
The hidden HIV epidemic: what do mathematical models tell us? The case of France Virginie Supervie, Jacques Ndawinz & Dominique Costagliola U943 Inserm.
Treatment as prevention (TASP) for HIV and HCV: The evidence and modelling Peter Vickerman.
Attaining Realistic and Substantial Reductions in HIV Incidence: Model Projections of Combining Microbicide and Male Circumcision interventions in Rural.
Ecological Model for HIV Risk in MSM Stage of Epidemic Individual Community Public Policy Network Level of Risks Source: Baral and Beyrer, 2006.
The Global Epidemiology of HIV among Female Sex Workers: The Influence of Structural Determinants Shannon K, Strathdee SA, Goldenberg S, Duff P, Mwangi.
GAP Report 2014 Prisoners People left behind: Prisoners Link with the pdf, Prisoners.
HIV Modelling & Economics Estimating the potential impact and efficiency of PrEP for FSWs and MSM in Bangalore, southern India K.M. Mitchell 1, H.J. Prudden.
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
The Effect of Opioid Agonist Maintenance Therapy on Healthcare Utilization and Engagement among HIV-infected People Who Inject Drugs in.
Comprehensive HIV Prevention Strategies for Most at Risk Populations (MARPs) Anne Goldzier Thomas, Ph.D. US Department of Defense/PEPFAR Ethiopia National.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
Effects of an HIV/AIDS peer prevention intervention on sexual and injecting risk behaviors among injecting drug users (IDUs) and their risk partners in.
HIV and AIDS Data Hub for Asia-Pacific HIV and AIDS Data Hub for Asia-Pacific Review in slides China 1.
Theodore M. Hammett, Ph.D. Sofia Kennedy, M.P.H. Drug Abuse and Risky Behaviors: The Evolving Dynamics of HIV/AIDS NIH-Bethesda, MD May 9, 2007 HIV/AIDS.
Resource Needs Model Rachel Sanders October 28 th, 2010.
Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London.
School of Public Health and Community Medicine How policies and repressive law- enforcement fuel the HIV epidemic among people who inject drugs Professor.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Maldives Last updated: December 2014.
HIV and AIDS Data Hub for Asia-Pacific Review in slides India.
Prevention, Treatment and Care of Hepatitis C among People Who Inject Drugs Jason Grebely, PhD Senior Lecturer Viral Hepatitis Clinical Research Program.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: January 2016.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS H HIV Prevention for Female Sexual Partners of People Who Inject Drugs: Evaluation Results Theodore.
Estimating the population impact of homelessness on HIV viral suppression among people who use drugs Brandon DL Marshall, 1 Beth Elson, 1 Sabina Dobrer,
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan.
Zindoga Mukandavire Social and Mathematical Epidemiology Group London School of Hygiene and Tropical Medicine, UK Improving health worldwide
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: November 2014.
Harm reduction evidence: Eastern Europe and Central Asia Raminta Stuikyte Central and Eastern European Harm Reduction Network.
Center for Studies of Addiction, University of Pennsylvania, USA
HPTN 071 (PopART): Have we reached the targets after two years of the PopART intervention IAS Paris July 2017 Richard Hayes.
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
Pengjun Lu, PhD, MPH;1 Kathy Byrd, MD, MPH;2
HPTN Modelling Centre symposium “Recent advances in mathematical modelling to inform HIV prevention research activities and directions” IAS 2017 in.
Fabienne Hariga Senior Adviser, HIV/AIDS Section
Incarceration and People Who Inject Drugs in Ukraine: Modelling its Role in HIV Transmission and the Impact of Introducing OST in Prisons Jack Stone, Ellen.
Maldives Last updated: September 2016.
HIV treatment cascade analysis for people who inject drugs in Ukraine: identifying the correlates of HIV care outcomes Kostyantyn Dumchev1, Olga Varetska2,
Jessica Haberer, MD, MS July 24, 2017
Kristen Williams, Jonathan J.K. Stoltman, and Mark K. Greenwald
Pakistan Last updated: July 2015.
Global burden of HIV, viral hepatitis and TB in prisoners
Jack Stone, April Young, Jennifer R. Havens, Peter Vickerman
Documenting barriers to access HCV care and treatment: a peer-led research João Santa Maria, Magda Ferreira, Renato Pinto, Joana Sanches, Álvaro Ávila,
Modeling the impact of the Mexican drug law reform on HIV incidence among people who inject drugs (PWID) in Tijuana, Mexico. Add other affiliations for.
Coverage of HIV and HCV prevention interventions for people who inject drugs Dr Sarah Larney, Senior Research Fellow.
Engagement in methadone maintenance therapy associated with less time with plasma HIV-1 RNA viral load above 1500 copies/mL among a cohort of HIV-positive.
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Brief overview of HIV among MSM in the EU/EEA
Edward Mbizo Sibanda, (MSc) Right to Care
Causes and Predictors of Mortality among People who Inject Drugs in Tijuana: IAS Conference: July 23, 2018 Brooke S. West, Daniela Abramovitz,
Evaluating the cost-effectiveness of the test and treat program in Zimbabwe
Global Optimization of the Response to HIV
The HIV Epidemic among People who Inject Drugs
SEXUAL RISK BEHAVIOR OF PLWHA IN THE WA MUNICIPALITY
The effect of public health-oriented drug law reform on HIV incidence in people who inject drugs in Tijuana, Mexico: an epidemic modelling study  Annick.
2018 Postgraduate Research Symposium: Exploring opportunities
Myanmar Last Update: November 2014.
Key Affected Populations
Progress in Facilitating National HCV Prevention
Volume 393, Issue 10178, Pages (March 2019)
Volume 388, Issue 10049, Pages (September 2016)
Progress on Voluntary Medical Male Circumcision for HIV prevention and How VMMC fits into UNAIDS ' ' target Julia Samuelson, Nurse epidemiologist.
Trends in the HIV incidence rate following ART scale-up in a rural and hyper-endemic South Africa population (2004–2015) Alain Vandormael, PhD School of.
No conflicts of interest
Japan Last updated: April 2019.
Implementation Experiences & Insights from the Scale-Up of an HIV Assisted Partner Notification Intervention in Central Asia Kristen M. Little, Maxim Kan,
Share your thoughts on this presentation with #IAS2019
Presentation transcript:

Modeling the potential impact of providing ART and OAT in prison and upon release on HIV incidence among PWID in Tijuana, Mexico Add other affiliations for Leo and Natasha Annick Bórquez, Daniela Abramovitz, Leo Beletsky, Steffanie A. Strathdee, Peter Vickerman, MC Boily, Natasha K Martin Division of Global Public Health, University of California San Diego Lisbon Addictions, 10/25/2017

Conflict of interest None to declare

Incarceration as an opportunity to reach PWID with health services Incarceration has been consistently associated with increased risk of bloodbourne infections among PWID1-2 Right to health in prison is an international norm WHO/UNODC recommend comprehensive package of HIV prevention, care, and support for incarcerated people2 Prisons as opportune settings to: Reach PWID with health services since low access in the community3 Start opioid agonist therapy (OAT) and antiretroviral treatment (ART), as treatment can be directly observed and monitored2-3 Quantifying the potential impact of implementing HIV and OAT interventions in prison is important to inform policy making and advocate for change Dolan K, Wirtz AL, Moazen B, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners 18 and detainees. Lancet 2016 Csete J. et al. Public health and international drug policy, The Lancet Commissions, 2016; 387: 1427–80 Beyrer C, et al. Prisoners, prisons, and HIV: time for reform. The Lancet, July 14 2016 Risks inside prison as less to no access to sterile syringes/condoms Risks upon release as a result of hardship (homelessness, unemployment) and regaining access to drugs

Tijuana, as case study Large PWID population (5,000-10,000) “Proyecto El Cuete IV”: cohort study following 734 PWID in Tijuana bi- annually from 2011-2020 HIV test self-reports of sexual and drug- using behaviors, policing, incarceration, and access to HIV and harm reduction services Among PWID, HIV prevalence is 3.5%, HIV incidence is 1-2%/year Access to HIV and harm reduction services is very low (<3% receiving ART or OAT)

Prison as a setting to reach PWID in Tijuana 85% and 59% of male and female PWID have ever been incarcerated Mean number of 5 (SD: 4.6) and 3 (SD: 2.7) incarcerations since starting injecting for male and female PWID, respectively Average sentence length: 4 months

Aims Use mathematical modeling to: 1) Estimate the potential impact of providing ART or/and OAT in prisons and upon release on HIV incidence among PWID in Tijuana 2) Assess the impact of also scaling up ART and OAT among PWID in the community Graph to justify aim 2: more likely to implement these services I the community than in prison according to experiences from countries which have done either or both so exploring this scenario too (even if the main aim of this study is to explore the use of prisons as settings to link PWID to health services Source: Csete J. et al. The Lancet Commissions, 2016

Methods Dynamic, deterministic compartmental model of HIV transmission among PWID Injecting and sexual transmission Disaggregated by sex, incarceration stage, OAT and HIV stage including ART Varied parameters associated with demography, incarceration patterns and HIV transmission Fitted to data on HIV prevalence and incidence using Latin Hypercube Sampling and resampled best fitting simulations

Intervention scenarios ART OAT Prison and release Community Scenario 1 Scenario 2 Scenario 3 Scenario 4 Coverage of ART/OAT in the “community scenario” varies because I use a rate and it translates into different coverages depending on the epidemic projection. These are not the exact min and max, will provide these.

Intervention characteristics ART OAT Prison Community Efficacy 30%-75% reduction in sexual and injecting transmission 54%(33%-68%) reduction in acquisition through injecting Drop out rate 0/year 0.2/year 1/year Coverage S-1 100% declines 0% Coverage S-2 Coverage S-3 Coverage S-4 45-55% 20%-30%

Model diagram: Scenario 1 Scenario 2 Scenario 3 Scenario 4 Never Incarcerated Recently Incarcerated Not Recently Incarcerated Prison Off OAT On OAT Off ART On ART

Proportion of new HIV infections averted among PWID in Tijuana from 2018 to 2030 through providing ART or/and OAT in prison and upon release. Mean: 45.8% Mean: 30.1% Mean: 20.2% Mean: 18.5%

Conclusions Prisons could provide a valuable opportunity for initiating PWID on to HIV and drug treatment in Tijuana Nearly a third of new HIV infections could be averted between 2018-2030 through the provision of ART and OAT in prison, conditional on linkage upon release. Substantial (although still suboptimal) scale up of ART and OAT in the community would further curb the epidemic by preventing nearly 50% of new HIV infections

Limitations and future work Self reported behaviors Model’s capacity to reproduce epidemic dynamics Future work should examine: Explore feasibility of implementing these services in prisons in Tijuana through qualitative interviews with previously incarcerated PWID, health care providers in prison and decision makers. Explore synergies between OAT and ART adherence and incarceration rates Evaluate cost-effectiveness Bayesian sensitivity

Acknowledgments Thank you! Funding: -NIDA U.S.-Mexico drug abuse prevention research fellowship -UC-MEXUS CONACyT postdoctoral fellowship -UC San Diego Center for AIDS Research (NIAID P30 AI36214) -NIDA grant R01 DA0 19829 -NIDA grant R01 DA037773-01A1 Patty González Zúñiga Kenya Lazos All the participants of El Cuete study Thank you! Pictures from “Tomorrow is a long time: Tijuana’s unchecked HIV/AIDS epidemic” by John Cohen and Malcom Linton

Extra slides

Model fitting:

Modeling Analysis: Never incarcerated Prison 2012 2017 Baseline Never incarcerated Prison Recently incarcerated (< 6 months ago) Previously Incarcerated (> 6months ago) Number of new HIV infections Reproduce observed trends Simplified cohort model used to estimate: -Proportion ever incarcerated when starting injecting -Primary incarceration rate RR HIV RR HIV